covid-19 vaccine hipra
Vaccineexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Aug 16, 2021 (NCT05007509)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05305573 | Phase 2 | Mar 25, 2022 | Laboratorios Hipra, S.A. |
| NCT05142553 | Phase 2 | Nov 16, 2021 | Laboratorios Hipra, S.A. |
| NCT05142514 | Phase 2 | Nov 11, 2021 | Government of Vietnam, Laboratorios Hipra, S.A. |
| NCT05007509 | Phase 1/Phase 2 (Phase 2) | Aug 16, 2021 | Laboratorios Hipra, S.A. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Laboratorios Hipra, S.A. | For profit | 4 | 4 | 1 | 2021 |
| Government of Vietnam | Government | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1